NCT01006460

A Study With Arctic Root Compared With the Extract When Combined With Schizandra and Russian Root (Adapt 232), Standardized Ginseng Extract and Placebo Regarding Impact on the Level of Energy, Ability to Work Under Stress, Quality of Life and Wellbeing, in Middleaged Women Who Are Still Employed

A Randomized, Placebo Controlled, Parallel, Double Blinded Trial With Rhodiola Rosea Extract SHR-5 (Arctic Root) Compared With the Extract When Combined With Schizandra and Russian Root (Adapt 232), Standardized Ginseng Extract and Placebo Regarding Impact on the Level of Energy, Ability to Work Under Stress, Quality of Life and Wellbeing, in Middleaged Women Who Are Still Employed

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Frederiksberg University Hospital · Academic / Other
• Sex: Female
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

This is clinical trial to document the efficacy of a proprietary standardized extract of Arctic root in comparison to a standardized commercial extract of ginseng and placebo from an every day consumer perspective to ameliorate mild depression, reduce stress and improve quality of life. A newly developed adaptogenic formulation, Adapt 232, was included into the study in order to evaluate its effect in comparison to the others.

Conditions

• Depression
• Stress

Interventions

Type	Name	Description
DRUG	Rhodiola rosea, L	3 Capsules twice a day
DRUG	Rhodiola rosea, L., Eleutherococcus senticosus, Schisandra chinensis	3 capsules twice a day
DRUG	Panax ginseng	3 capsules twice a day
DRUG	Placebo - dark brown sugar	3 capsules twice a day

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-07-01
• Completion: 2010-08-01
• First posted: 2009-11-02
• Last updated: 2010-08-27

Locations

1 site across 1 country: Denmark